China Biologic Products Holdings, Inc. (CBPO) Given Average Recommendation of “Strong Buy” by Brokerages

Shares of China Biologic Products Holdings, Inc. (NASDAQ:CBPO) have been given an average broker rating score of 1.00 (Strong Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. Three investment analysts have rated the stock with a strong buy recommendation.

Analysts have set a 12-month consensus price target of $111.67 for the company and are predicting that the company will post $1.11 EPS for the current quarter, according to Zacks. Zacks has also given China Biologic Products an industry rank of 157 out of 265 based on the ratings given to related companies.

Several research firms have issued reports on CBPO. Zacks Investment Research upgraded shares of China Biologic Products from a “sell” rating to a “hold” rating in a research report on Wednesday, November 15th. BidaskClub upgraded shares of China Biologic Products from a “strong sell” rating to a “sell” rating in a research report on Wednesday, December 20th.

Institutional investors have recently modified their holdings of the company. Comgest Global Investors S.A.S. boosted its position in shares of China Biologic Products by 135.0% during the 3rd quarter. Comgest Global Investors S.A.S. now owns 356,252 shares of the biopharmaceutical company’s stock valued at $32,872,000 after acquiring an additional 204,649 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of China Biologic Products by 30.1% during the 3rd quarter. Bank of New York Mellon Corp now owns 762,784 shares of the biopharmaceutical company’s stock valued at $70,380,000 after acquiring an additional 176,325 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of China Biologic Products by 4.9% during the 2nd quarter. Goldman Sachs Group Inc. now owns 61,404 shares of the biopharmaceutical company’s stock valued at $6,945,000 after acquiring an additional 2,845 shares in the last quarter. Hillhouse Capital Management Ltd. boosted its position in shares of China Biologic Products by 186.8% during the 2nd quarter. Hillhouse Capital Management Ltd. now owns 753,624 shares of the biopharmaceutical company’s stock valued at $85,235,000 after acquiring an additional 490,874 shares in the last quarter. Finally, WCM Investment Management CA acquired a new stake in shares of China Biologic Products during the 3rd quarter valued at about $4,268,000. Institutional investors and hedge funds own 65.13% of the company’s stock.

Shares of China Biologic Products (CBPO) opened at $82.34 on Wednesday. The stock has a market cap of $2,630.00, a price-to-earnings ratio of 21.44, a price-to-earnings-growth ratio of 1.00 and a beta of 1.79. China Biologic Products has a 12-month low of $72.21 and a 12-month high of $120.46.

COPYRIGHT VIOLATION NOTICE: “China Biologic Products Holdings, Inc. (CBPO) Given Average Recommendation of “Strong Buy” by Brokerages” was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.com-unik.info/2018/01/10/china-biologic-products-holdings-inc-cbpo-given-average-recommendation-of-strong-buy-by-brokerages.html.

About China Biologic Products

Get a free copy of the Zacks research report on China Biologic Products (CBPO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for China Biologic Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Biologic Products and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit